Adverse Events: A Classification System for Use in Clinical Trials

Abstract

Accompanying this article are two very succinct reviews, one authored by Enas and the other by Huster. They present important and timely information on methods of analysis of adverse event data and the alternative benefits and shortcomings of such analyses. I was originally asked to provide a medical perspective of the information presented by Enas and Huster. In preparing this perspective, it became clear that some improvement in the recognition of various roles of adverse event data was desirable. This paper is an attempt to delineate a classification of adverse event data.